Lipoprotein(a) linked to elevated cardiovascular risk despite standard treatment

New data analyzing more than 20,000 patients from three major NIH studies show that elevated Lipoprotein(a) [Lp(a)] is associated with residual cardiovascular risk and warrants aggressive risk reduction. Researchers presented the data at the Society for Cardiovascular Angiography & Interventions (SC